Search for: "C & S Company, Inc." Results 2301 - 2320 of 7,898
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
1 Aug 2018, 6:01 am
Posted by Lyla Qureshi, Equilar, Inc., on Wednesday, August 1, 2018 Editor's Note: Lyla Qureshi is a Research Analyst at Equilar. [read post]
31 Jul 2018, 10:40 am by Kevin Kaufman
Most established, profitable companies in Connecticut have little reason to be concerned with the state’s capital stock tax, since it functions as a minimum tax within the corporate income tax, but new and expanding companies can be penalized by it, as can businesses that are struggling to survive. [read post]
27 Jul 2018, 10:14 am by luiza
The settlement resolves allegations in a lawsuit brought in 2016 by Moldex Metric, Inc. [read post]
27 Jul 2018, 6:12 am by Overhauser Law Offices, LLC
§ 1125(c) as the use of the infringing marks is likely to blur the distinctiveness of the marks and tarnish the good name of Oakley. [read post]
25 Jul 2018, 12:54 pm by Robert Wernli, Jr.
The Doing Business Test – Is the average of the corporation’s (a) property factor, (b) payroll factor and (c) sales factor more than 50% during the corporation’s last full income year? [read post]
22 Jul 2018, 9:00 pm by Cookson Beecher
According to the Australian Camel Industry Association, camel milk has five times the vitamin C and 10 times the iron compared to cow’s milk. [read post]
22 Jul 2018, 1:39 pm
S. 298 (1992), and National Bellas Hess, Inc. v. [read post]
20 Jul 2018, 1:02 pm by luiza
By the C|C Whistleblower Lawyer Team This week’s Department of Justice “Catch of the Week” goes to New York-based medical device maker AngioDynamics, Inc. [read post]
20 Jul 2018, 8:59 am by Camilla Alexandra Hrdy
While hardly empirically bulletproof, Risch's example suggests that a contract-only regime does a sufficiently worse job at protecting information as to make a difference in companies' expenditures on precautions. [read post]
18 Jul 2018, 11:23 am by Tryn T. Stimart and Jean E. Dassie
Teva Pharmaceuticals USA, Inc., a case with broad implications for the pharmaceutical industry. [read post]